Determination of the Prevalence of Microsatellite Instability, BRAF and KRAS/NRAS Mutation Status in Patients with Colorectal Cancer in Slovakia

被引:0
|
作者
Rendek, Tomas [1 ]
Saade, Rami [2 ]
Pos, Ondrej [3 ,4 ]
Kolnikova, Georgina [5 ]
Urbanova, Monika [5 ]
Budis, Jaroslav [3 ,4 ]
Mihok, Luboslav [6 ]
Tomas, Miroslav [7 ]
Szemes, Tomas [3 ,4 ]
Repiska, Vanda [1 ]
机构
[1] Comenius Univ, Inst Med Biol Genet & Clin Genet, Fac Med, Bratislava 81108, Slovakia
[2] Comenius Univ, Fac Med, Dept Gynaecol & Obstet 2, Bratislava 81108, Slovakia
[3] Geneton Ltd, Bratislava 84104, Slovakia
[4] Comenius Univ, Sci Pk, Bratislava 84104, Slovakia
[5] NCI, Dept Pathol Anat, Bratislava 83310, Slovakia
[6] NCI, Dept Med Genet, Bratislava 83310, Slovakia
[7] Slovak Med Univ, NCI, Surg Oncol Clin, Bratislava 83310, Slovakia
关键词
microsatellite instability; colorectal cancer; BRAF; KRAS; NRAS mutations; RAS MUTATIONS; KRAS; BENEFIT;
D O I
10.3390/cancers16061128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Slovakia has one of the highest rates of colorectal cancer among the developed countries, ranking as the second highest in the incidence of this disease for men worldwide. Despite the significant burden on both quality of life and the healthcare system this disease imposes, data on molecular analysis of biomarkers in CRC-diagnosed patients is scarce. In our study, we analyzed confirmed CRC patients from the database of the National Cancer Institute (NCI) and evaluated the presence of 4 biomarkers in tumor tissues. Altogether, 83 FFPE tumor tissues from CRC patients listed in the NCI database were analyzed for microsatellite instability status, presence of BRAF and KRAS/NRAS mutations, and neoplastic cell percentage in tissue samples. We identified 4 MSI-high samples, 39 KRAS/NRAS mutations, and 5 BRAF p.V600E mutations, with one case of coexistence of all three markers in a single tumor sample. We also evaluated possible relationships between biomarkers, their coexistence, and the age and sex of the studied population.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma
    Bagadi, Sarita B.
    Sanghvi, Meera
    Nair, Sudish B.
    Das, Bibhu R.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (01) : 27 - 33
  • [42] Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
    de Cuba, E. M. V.
    Snaebjornsson, P.
    Heideman, D. A. M.
    van Grieken, N. C. T.
    Bosch, L. J. W.
    Fijneman, R. J. A.
    Belt, E.
    Bril, H.
    Stockmann, H. B. A. C.
    Hooijberg, E.
    Punt, C. J. A.
    Koopman, M.
    Nagtegaal, I. D.
    Coupe, V. H. M.
    Carvalho, B.
    Meijer, G. A.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (05) : 1139 - 1145
  • [43] Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
    Modest, D. P.
    Ricard, I.
    Heinemann, V.
    Hegewisch-Becker, S.
    Schmiegel, W.
    Porschen, R.
    Stintzing, S.
    Graeven, U.
    Arnold, D.
    von Weikersthal, L. F.
    Giessen-Jung, C.
    Stahler, A.
    Schmoll, H. J.
    Jung, A.
    Kirchner, T.
    Tannapfel, A.
    Reinacher-Schick, A.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1746 - 1753
  • [44] Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis
    Amaki-Takao, Misato
    Yamaguchi, Tatsuro
    Natsume, Soichiro
    Iijima, Takeru
    Wakaume, Rika
    Takahashi, Keiichi
    Matsumoto, Hiroshi
    Miyaki, Michiko
    ONCOLOGY, 2016, 91 (03) : 162 - 170
  • [45] KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
    Radanova, Maria
    Mihaylova, Galya
    St Stoyanov, George
    Draganova, Vyara
    Zlatarov, Aleksandar
    Kolev, Nikola
    Dimitrova, Eleonora
    Conev, Nikolay
    Ivanova, Diana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [46] KRAS and BRAF mutations in Serbian patients with colorectal cancer
    Jakovljevic, K.
    Malisic, E.
    Cavic, M.
    Krivokuca, A.
    Dobricic, J.
    Jankovic, R.
    JOURNAL OF BUON, 2012, 17 (03): : 575 - 580
  • [47] The Mutation Profiles of KRAS and BRAF Genes in a Romanian Colorectal Cancer Cohort
    Brinzan, Costel
    Aschie, Mariana
    Grasa, Catalin Nicolae
    Mitroi, Anca Florentina
    Matei, Elena
    Cozaru, Georgeta Camelia
    REVISTA DE CHIMIE, 2019, 70 (04): : 1346 - 1350
  • [48] Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran
    Yari, Abolfazi
    Samoudi, Arash
    Afzali, Asiyeh
    Karam, Zahra Miri
    Karimaldini, Negin Khaje
    Abadi, Maryam Fekri Soofi
    Ziasistani, Mahsa
    Zangouey, Mohammad Reza
    Dabiri, Shahriar
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (02) : 557 - 568
  • [49] Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran
    Abolfazl Yari
    Arash Samoudi
    Asiyeh Afzali
    Zahra Miri Karam
    Negin Khaje Karimaldini
    Maryam Fekri Soofi Abadi
    Mahsa Ziasistani
    Mohammad Reza Zangouey
    Shahriar Dabiri
    Journal of Gastrointestinal Cancer, 2021, 52 : 557 - 568
  • [50] Tumor profiling of KRAS, BRAF, and NRAS gene mutations in patients with colorectal cancer: A Lebanese major center cohort study
    Baba, Omar
    Bidikian, Aram
    Mukherji, Deborah
    Shamseddin, Ali
    Temraz, Sally
    Fakhruddin, Najla
    Khazzouh, Mira
    Ghizzawi, Diana
    Khalek, Rabab Abdel
    Zaatari, Ghazi
    Mahfouz, Rami
    GENE, 2022, 834